Integrated Symposium
Join us for our lunch symposium
on April 25, 12:15-1:15 pm - HALL Q
Faster ID and AST revolution:
How to improve antibiotic use in the critically ill?
🕛 12:15 PM - 12:30 PM
📢 Introduction & talk on how to improve antibiotic use in the critically ill with faster ID & AST
(Prof. Mervyn Singer)
🕧 12:30 PM - 1:00 PM
📢 Round table with experts on the use of multiplex PCR to treat patients affected with Pneumonia and Bloodstream infections
(Prof. Mervyn Singer, Dr. Vanya Gant, Prof. Gian Maria Rossolini)
🕐 1:00 PM - 1:15 PM
❓ LIVE Q&A with all attendees & speakers
Speakers
 |
Prof. Mervyn Singer University College London, UK |
 |
Dr. Vanya Gant University College London Hospitals NHS Foundation Trust, UK |
 |
Prof. Gian Maria Rossolini Careggi University Hospital, Florence, IT |
Moderated by
 |
Prof. Laurence Armand-Lefèvre Bichat University Hospital, APHP, FR |
ESCMID appointed chair
Prof. John D. Turnidge
University of Adelaide, AU
Refreshment will be served
Booth Highlights
MEET US ON THE BOOTH TO DISCOVER OUR LATEST INNOVATIONS ON:
SEPSIS
When a patient presents with suspected sepsis, optimized outcomes depend on antibiotic treatment being started rapidly
RESPIRATORY INFECTIONS & TB
Lower respiratory tract infections (LRTI) and tuberculosis are among the most deadly communicable diseases – and the causes can be particularly difficult to identify.
FAST IDENTIFICATION
Offering faster identification enables labs to positively impact time to appropriate patient care, risk of mortality, outbreak prevention, length of stay and hospital costs.
OPTIMIZED & INTEGRATED WORKFLOW
Innovative technologies enable labs to not only meet daily challenges but to deliver more, through optimized, integrated workflow.
ADVANCED ANALYTICS & DECISION SUPPORT
Effective collection, consolidation and analysis of information with is a game-changer for epidemiology and outbreak prevention and control.
TO BETTER SUPPORT ANTIMICROBIAL STEWARDSHIP
Scientific Posters & Oral Presentations
Check out bioMérieux’s scientific posters and presentations at ECCMID
| Product | Poster title | Co-authors | Session Name | Date and Time |
|---|---|---|---|---|
| MICROBIO | ||||
|
VITEK MS |
Identification of Mycobacterium and Nocardia species by MALDI-TOF using VITEK MS |
Dr. Belen Rodriguez, Hospital General Universitario Gregorio Marañón, Madrid, Spain |
04. Diagnostic microbiology 4c. MALTI-TOF and other proteomic methods |
Monday, 25.04.2022 12:00 - 13:00 |
|
VITEK2 AES |
Performance of the VITEK 2 Advanced Expert System (AES) as a Rapid Tool for Reporting Antimicrobial Susceptibility Testing (AST) in Enterobacterales |
Dr. Cecilia Carvalhaes, JMI Labs, Iowa, USA |
04. Diagnostic microbiology 4a. Diagnostic bacteriology – culture based and general microbiology |
Monday, 25.04.2022 12:00 - 13:00 |
|
VIRTUO |
Comparison between the BACT/ALERT® VIRTUO™ and the BACTEC™ FX automated blood culture systems: time to detection and workflow efficiency |
Dr. Ana Halperin, Hospital Universitario Ramón y Cajal-IRYCIS, Madrid, Spain |
02. Bacterial infection & disease 2b. Severe |
Sunday, 24.04.2022 12:00 - 13:00 |
|
VIRTUO |
Efficient growth of Candida species from simulated BacT/Alert or Bactec blood cultures in the presence of clinically relevant antifungal drug concentrations |
Dr. Giulia Menchilini, Universitario A. Gemelli IRCCS, Rome, Italy |
6. Fungal infection & disease 6b. Diagnostic mycology |
Monday, 25.04.2022 12:00 - 13:00 |
|
Lab Consultancy |
Conversion from a classic microbiology laboratory to an automated one in times of pandemic: summary of the optimised integration of WASPLAB and VITEK MS at the Dr. Joaquim Chaves, Clinical Analysis Laboratory, Department of Microbiology, Lisbon |
Dr. R. Pinto, Joaquim Chaves Saude Microbiology Laboratory, Lisbon, Portugal |
04. Diagnostic microbiology 4b. Lab management |
Monday, 25.04.2022 12:00 - 13:00 |
| CHROMID MDRO |
Prevalence and risk factors associated with the colonization of multidrug-resistant gram negative bacilli in long-term care facilities |
Dr. Maria Lecuona, Hospital Universitario de Canarias, Tenerife, Spain |
03. Bacterial susceptibility & resistance 3b. Resistance surveillance & epidemiology: Gram-negatives |
Sunday, 24.04.2022 12:00 - 13:00 |
|
CHROMID® CPSE |
Reduced incubation time of chromogenic specific medium combined with lab automation and artificial intelligence-based software for a faster time-to-result of urine specimens |
Dr Arnaud FRANCOIS, BIOESTEREL Group, France |
4b. Lab management |
Monday, 25.04.2022 12:00 - 13:00 |
| IMMUNO | ||||
|
VIDAS TB IGRA
|
A new reliable alternative for the diagnosis of Mycobacterium tuberculosis infection |
Dr. Ali Esmail & Pr. Keertan Dheda, University of Cape Town, Cape Town, South Africa |
02. Bacterial infection & disease 2a. Tuberculosis & other mycobacterial infections |
Sunday, 24.04.2022 12:00 - 13:00 |
| MOLECULAR | ||||
|
BIOFIRE BCID/BCID2 panel |
Direct identification of microorganisms in positive blood cultures by BioFire FilmArray Blood Culture Identification Panel leads to faster optimal antimicrobial therapy: a before-after study |
J. Agnetti* (Basel, Switzerland) |
04. Diagnostic microbiology
4d. Molecular diagnostic ( including POCT and syndromic testing) |
Monday, 25.04.2022 12:00 - 13:00 |
|
BIOFIRE BCID/BCID2 panel |
The impact of an add-on multiplex molecular assay on the management of bloodstream infections in hospitalised patients at Princess Marina Hospital in Botswana: a randomised controlled trial |
J. Pernica* (Hamilton, Canada) |
04. Diagnostic microbiology
4d. Molecular diagnostic ( including POCT and syndromic testing)
|
Monday, 25.04.2022 12:00 - 13:00 |
|
BIOFIRE BCID/BCID2 panel |
The impact of using rapid-blood-culture-identification on bloodstream infections in a developing country |
S. Castro* (Rio De Janeiro, Brazil) |
04. Diagnostic microbiology
4d. Molecular diagnostic ( including POCT and syndromic testing)
|
Monday, 25.04.2022 12:00 - 13:00 |
|
BIOFIRE JI panel |
Evaluation of clinical usefulness of a commercial multiplex PCR for the diagnosis of osteoarticular infections |
J. Esteban* (Madrid, Spain) |
04. Diagnostic microbiology
4d. Molecular diagnostic ( including POCT and syndromic testing)
|
Monday, 25.04.2022 12:00 - 13:00 |
|
BIOFIRE JI panel |
Evaluation of the performance of a commercial bone and joint infection (BJI) molecular panel and comparison with standard culture methods for the detection of orthopaedic infections |
N. Reidy* (Dublin, Ireland) |
04. Diagnostic microbiology
4d. Molecular diagnostic ( including POCT and syndromic testing)
|
Monday, 25.04.2022 12:00 - 13:00 |
|
BIOFIRE BCID/BCID2 panel |
Implementation of the multi-pathogen detection panel: impact on the clinical microbiology laboratory and improved antimicrobial stewardship |
M. Pitts* (Dublin, Ireland) |
04. Diagnostic microbiology
4d. Molecular diagnostic ( including POCT and syndromic testing)
|
Monday, 25.04.2022 12:00 - 13:00 |
|
BIOFIRE BCID/BCID2 panel |
A commercial blood culture identification 2 panel for rapid detection of causative agents of bacteraemia in critically ill patients: evaluation of the clinical impact |
C. Mauri* (Lecco, Italy) |
04. Diagnostic microbiology
4d. Molecular diagnostic ( including POCT and syndromic testing)
|
Monday, 25.04.2022 12:00 - 13:00 |
|
BIOFIRE BCID/BCID2 panel |
Evaluation of the performance of the BCID2 molecular panel for the diagnosis of complicated intra-abdominal infections |
T. Nicol* (Angers, France) |
04. Diagnostic microbiology
4d. Molecular diagnostic ( including POCT and syndromic testing)
|
Monday, 25.04.2022 12:00 - 13:00 |
|
BIOFIRE BCID/BCID2 panel |
Correlation of the BCID2 panel with phenotypic blood culture results in an Indian ICU: a single-centre retrospective observational study |
S. Shetty* (Mumbai, India) |
04. Diagnostic microbiology
4d. Molecular diagnostic ( including POCT and syndromic testing)
|
Monday, 25.04.2022 12:00 - 13:00 |
|
BIOFIRE Fever panel |
Severe case of leptospirosis diagnosed with multiplex PCR and next-generation sequencing of cell-free DNA |
H.M. Orth* (Düsseldorf, Germany) |
04. Diagnostic microbiology
4d. Molecular diagnostic ( including POCT and syndromic testing)
|
Monday, 25.04.2022 12:00 - 13:00 |
|
BIOFIRE GI panel |
Results of a commercial gastrointestinal panel and serum procalcitonin in acute colitis and infectious diarrhoea in the emergency department |
M. Cancella De Abreu* (Paris, France) |
04. Diagnostic microbiology
4d. Molecular diagnostic ( including POCT and syndromic testing)
|
Monday, 25.04.2022 12:00 - 13:00 |
|
BIOFIRE JI panel |
Diagnostic utility of a syndromic multiplex polymerase chain reaction panel in bone and joint infections |
T. Hoffman* (Ramat Gan, Israel) |
04. Diagnostic microbiology
4d. Molecular diagnostic ( including POCT and syndromic testing)
|
Monday, 25.04.2022 12:00 - 13:00 |
|
BIOFIRE ME panel |
Rapid CSF analysis using a commercial multiplex PCR assay leads to improved AMS interventions, significant cost savings and a reduction in morbidity and mortality |
R. Traynor* (Dublin, Ireland) |
04. Diagnostic microbiology
4d. Molecular diagnostic ( including POCT and syndromic testing)
|
Monday, 25.04.2022 12:00 - 13:00 |
|
BIOFIRE ME panel |
Assessing the detection capability of molecular diagnostics using international standards and quantified control materials |
E. Amiott* (Salt Lake City, United States) |
04. Diagnostic microbiology
4d. Molecular diagnostic ( including POCT and syndromic testing)
|
Monday, 25.04.2022 12:00 - 13:00 |
|
BIOFIRE ME panel |
Outcomes of implementation of a multiplex PCR panel for meningoencephalitis in a tertiary hospital between 2017 and 2020 |
T.K. Teoh* (Limerick, Ireland) |
04. Diagnostic microbiology
4d. Molecular diagnostic ( including POCT and syndromic testing)
|
Monday, 25.04.2022 12:00 - 13:00 |
|
BIOFIRE ME panel |
Rapid molecular detection of central nervous system infections and its impact on antimicrobial stewardship |
L.S. Gücer* (Istanbul, Turkey) |
04. Diagnostic microbiology
4d. Molecular diagnostic ( including POCT and syndromic testing)
|
Monday, 25.04.2022 12:00 - 13:00 |
|
BIOFIRE ME panel |
Commercial meningoencephalitis panel in the diagnosis of central nervous system infections: stewardship and cost analysis in a paediatric hospital in Chile |
D. Benadof* (Santiago, Chile) |
04. Diagnostic microbiology
4d. Molecular diagnostic ( including POCT and syndromic testing)
|
Monday, 25.04.2022 12:00 - 13:00 |
|
BIOFIRE PN panel |
Evaluation of the diagnostic performance of a commercial pneumonia panel for microbiological diagnosis in patients with lower respiratory infections |
E. Becerril Vargas* (Mexico City, Mexico) |
04. Diagnostic microbiology
4d. Molecular diagnostic ( including POCT and syndromic testing)
|
Monday, 25.04.2022 12:00 - 13:00 |
|
BIOFIRE PN panel |
The impact of multiplex pneumonia panel test among patients with COVID-19 in intensive care unit |
S. Keske* (Istanbul, Turkey) |
04. Diagnostic microbiology
4d. Molecular diagnostic ( including POCT and syndromic testing)
|
Monday, 25.04.2022 12:00 - 13:00 |
|
BIOFIRE PN panel |
ICU clinicians’ beliefs about prescribing broad-spectrum antibiotics and attitudes towards rapid molecular diagnostics within the context of COVID-19 |
A.M. Pandolfo* (London, United Kingdom) |
04. Diagnostic microbiology
4d. Molecular diagnostic ( including POCT and syndromic testing)
|
Monday, 25.04.2022 12:00 - 13:00 |
|
BIOFIRE PN panel |
Diagnostic performance of the semi-quantitative multiplex commercial pneumonia panel for diagnostics of lower respiratory tract infections |
K.K. Søgaard* (Basel, Switzerland) |
04. Diagnostic microbiology
4d. Molecular diagnostic ( including POCT and syndromic testing)
|
Monday, 25.04.2022 12:00 - 13:00 |
|
BIOFIRE PN panel |
Performance of a multiplex PCR in critically ill COVID-19 patients with suspected ventilated hospital-acquired pneumonia or ventilator-associated pneumonia: a retrospective monocentric observational study |
A. Meybeck* (Tourcoing, France) |
04. Diagnostic microbiology
4d. Molecular diagnostic ( including POCT and syndromic testing)
|
Monday, 25.04.2022 12:00 - 13:00 |
|
BIOFIRE PN panel |
Utility of a 29-mRNA host-response assay, together with PCR-based rapid pathogen diagnostics to identify pneumonias in intensive care unit (ICU) patients |
V. Enne* (London, United Kingdom) |
04. Diagnostic microbiology
4j. Other novel diagnostic technologies
|
Monday, 25.04.2022 12:00 - 13:00 |
|
BIOFIRE RP/RP2.1 panel |
Consistency of respiratory viruses detection between nasopharyngeal swab and bronchoalveolar lavage in adults admitted for a suspected pneumonia: the importance of BAL testing |
D. Bouzid* (Paris, France) |
01.Viral infection & disease
1c. Influenza & respiratory viruses ●
|
Monday, 25.04.2022 12:00 - 13:00 |
|
BIOFIRE RP/RP2.1 panel |
Use of multiplex PCR in children with viral acute respiratory infections admitted to emergency department: before and during the COVID-19 pandemic |
P. Bernaschi* (Rome, Italy)
|
01.Viral infection & disease
1c. Influenza & respiratory viruses |
Monday, 25.04.2022 12:00 - 13:00 |
|
BIOFIRE RP/RP2.1 panel |
Comparison of the nasopharyngeal swab and nasal swab in syndromic testing of acute respiratory infections |
J. Keener* (Salt Lake City, United States)
|
01.Viral infection & disease
1c. Influenza & respiratory viruses
|
Monday, 25.04.2022 12:00 - 13:00 |
|
BIOFIRE RP/RP2.1 panel |
The changing epidemiology and diagnostic workflow for the detection of respiratory pathogens in the Irish paediatric population |
C. Moore* (Waterford, Ireland)
|
01.Viral infection & disease
1c. Influenza & respiratory viruses
|
Monday, 25.04.2022 12:00 - 13:00 |
| ORAL PRESENTATIONS | ||||
|
Lab Consultancy |
Improvement of pre-analytical workflow in a clinical laboratory using lean principles combined with lab automation: impact of the WASP® integration in Hospital General Universitario de Albacete, Spain |
V. Gonzalez (Madrid, Spain) |
What's fast, new and relevant in infectious disease diagnostics? |
Sunday, 24.04.2022, 17:00-17:10 |
|
NTM Elite Agar |
Clinical evaluation of a new selective medium for nontubreculosis Mycobacteria: a prospective multicenter study. |
Prof. Jaime Esteban (Madrid, Spain) |
What's fast, new and relevant in infectious disease diagnostics? |
Sunday 24.04.2022, 17:50-18:00 |
|
BIOFIRE PN panel |
Impact of a multiplex PCR assay for the diagnosis of bacterial pneumonia in COVID-19 patients on antibiotic prescribing decisions at five UK ICUs |
K. Roulston (London, United Kingdom) |
4. Diagnostic microbiology |
Tuesday, 26.04.2022 14:30 - 14:40 |
|
BIOFIRE PN panel |
Understanding critical care clinicians' beliefs of rapid multiplex molecular diagnostic tests in clinical practice: a qualitative application of the Necessity Concerns Framework |
A.M. Pandolfo (London, United Kingdom) |
4. Diagnostic microbiology |
Tuesday, 26.04.2022 14:30 - 14:40 |
|
BIOFIRE PN panel |
Impact of routine molecular point-of-care testing for respiratory pathogens in critically unwell patients with pneumonia: a pragmatic, open-label, randomised controlled trial |
Stephen Poole (Southampton, United Kingdom) |
4. Diagnostic microbiology |
Sunday, 24.04.2022 19:05 - 19:15 |
Visit us at ECCMID
From April 23-26, 2022, ECCMID is the opportunity to discover innovations from bioMérieux.
Join us to learn the very latest news in the field and network with leading colleagues from around the world.
We hope to see you there!
🌐 Online
📅 Onsite in Lisbon, Portugal from April 23 to 26
📍 Booth #1.11
